fashion -WSS

fashion

author：fashion 2025-09-06 01:57:49 - browse：199

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Supreme Court strikes down use of affirmative action
Next article： WHO calls for emergency meeting on new China virus, as cases spread

WSS

A disappointing year of Humira biosimilars

Medicare to cover more brain scans for Alzheimer’s patients

Senators start work on Medicare physician payment reform

Doctors find melanoma drugs effective against rare brain cancer

In early work, researchers turn to CRISPR to treat Alzheimer's

Cosmetics set for new safety regulation. Why the industry is on board

leisure time

fashion

knowledge

Heart attack and stroke risk calculators need revising

Key House panel plots a new health care package

Tori Bowie and the unacceptable rates of Black maternal death

Sanofi seeks simpler, safer CRISPR sickle cell cure

Sports medicine is finally prioritizing gender equality

The Readout: Gilead, Bernie Sanders, and other pharma news

Cancer drug shortages should be causing more outrage

A disappointing year of Humira biosimilars

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Industry veterans launch new biotech VC with $310M

entertainment

AI can’t replace a physician’s gut feeling

AI can’t replace a physician’s gut feeling

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Industry veterans launch new biotech VC with $310M

focus

knowledge

focus

leisure time